EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 15

Shatavari Asparagus racemosus Willd.

Also called: wild asparagus, Protasparagus racemosus (synonym)

Shatavari is a climbing asparagus whose root is used in Ayurvedic tradition, especially as a galactagogue (to support breast-milk supply). It is a different plant from the asparagus eaten as a vegetable (Asparagus officinalis).

Category
Botanical
Part used
Root
Strongest evidence
B Some positive trials
Native range
Native from tropical Africa to northern Australia (POWO: "Tropical Africa to N. Australia")
Reviewed
2026-10-29

Class 1 Well studied in people. No review stating a count was found. This entry cites 11 RCTs of shatavari root or root extract alone: oral, placebo-controlled, 2011-2026, 20 to 214 participants. The retracted trial (source [4]) is not counted. [2]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied3 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Shatavari does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Shatavari, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Breast-milk supply after childbirthBLactMed describes clinical results as mixed, often with herbal mixtures; one small well-done trial found greater prolactin and infant weight gain than placebo, while a 4-week trial of a shatavari mixture (64 women) found no difference. [1]
Milk volume in the first 72 hours after deliveryCA randomized, double-blind trial (113 women analyzed, 300 mg root extract twice daily for 72 hours) reported higher milk volume and earlier breast fullness than placebo; no adverse events occurred. [2]
Menopausal symptomsCAn 8-week, three-arm trial (135 women aged 45 to 65) found the shatavari-plus-ashwagandha combination improved menopause rating scores more than shatavari alone or placebo; it is a single trial from one research group. [3]

Main constituents: Steroidal saponins (shatavarins), asparagamine, racemosol, polysaccharides, mucilage, flavonoids and polyphenols [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • 300 mg of root extract twice daily for 72 hours after delivery (lactation trial). [2]
  • Fresh roots at 20 mg/kg three times daily for 30 days in a 60-woman placebo-controlled lactation trial. [1]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Lactation: LactMed states that the safety of wild asparagus has not been rigorously studied, but small clinical studies found no adverse effects in …

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    1 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • The safety of wild asparagus has not been rigorously studied; small clinical studies found no adverse effects in mothers or their nursing infants. [1]
  • In the 8-week menopause trial, mild adverse events were reported by four participants (one with nausea in the shatavari-only group). [3]
Quality

Identity, quality and standardization

  • Many lactation studies tested multi-herb products, so results cannot be attributed to shatavari alone; LactMed notes that results on one product may not apply to other products. [1]
  • A 2025 randomized trial of a standardized shatavari root extract in perimenopausal women (J Am Nutr Assoc) was retracted in 2026. [4]
Regulation

Regulatory status

  • US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [6]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Shatavarins Steroidal saponins (phytoestrogens, per LactMed) [P1]
  • Polysaccharides and mucilage Polysaccharides [P1]
  • Flavonoids and polyphenols Flavonoids and polyphenols [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 1 entry naming Asparagus racemosus (NDI 810, submitted 2013-10-21, as one ingredient of a multi-ingredient preparation). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of shatavari (Asparagus racemosus) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • Lactation: LactMed states that the safety of wild asparagus has not been rigorously studied, but small clinical studies found no adverse effects in mothers or their nursing infants; galactogogues should never replace evaluation and counseling on factors that affect milk production. [P1]

Sources for this profile

  1. NIH NICHD. Drugs and Lactation Database (LactMed). Wild Asparagus (revised 2026-07-15), 2026-07-15. ncbi.nlm.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs. List of Classifications (list last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  4. eCFR. 21 CFR 111.75 (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources

Sources

  1. NIH NICHD. Drugs and Lactation Database (LactMed). Wild Asparagus (revised 2026-07-15), 2026-07-15. ncbi.nlm.nih.gov
  2. Ajgaonkar A, et al. Shatavari (Asparagus racemosus Willd) root extract for postpartum lactation: a randomised, double-blind, placebo-controlled study. J Obstet Gynaecol 2025;45(1):2564168 (PMID 41055223), 2025-12. pubmed.ncbi.nlm.nih.gov
  3. Ademola J, et al. Efficacy and safety of Shatavari root extract (Asparagus racemosus) for menopausal symptoms: a randomized, double-blind, three-arm, placebo-controlled study. Front Reprod Health 2025;7:1654503 (PMID 41394012), 2025-11-27. pubmed.ncbi.nlm.nih.gov
  4. Statement of Retraction: A Standardized Asparagus Racemosus Root Extract Improves Hormonal Balance and Menstrual Health and Reduces Vasomotor Symptoms in Perimenopausal Women. J Am Nutr Assoc 2026;45(8):782 (PMID 42820926), 2026-10-01. pubmed.ncbi.nlm.nih.gov
  5. Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Asparagus racemosus Willd. (accessed 2026-10-29). powo.science.kew.org
  6. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  7. Gupta M, Shaw B. A double-blind randomized clinical trial for evaluation of galactogogue activity of Asparagus racemosus Willd. Iran J Pharm Res 2011;10(1):167-72 (PMID 24363697), 2011. pubmed.ncbi.nlm.nih.gov
  8. O'Leary MF, et al. Shatavari supplementation in postmenopausal women improves handgrip strength and increases vastus lateralis myosin regulatory light chain phosphorylation but does not alter markers of bone turnover. Nutrients 2021;13(12):4282 (PMID 34959836), 2021-11-27. pubmed.ncbi.nlm.nih.gov
  9. Greed E, et al. Shatavari supplementation during eight weeks of resistance training increases training load, enhances skeletal muscle contractility and alters the skeletal muscle proteome in older women. Front Nutr 2024;11:1498674 (PMID 39834460), 2025-01-06. pubmed.ncbi.nlm.nih.gov
  10. Mahajan S, et al. Efficacy and safety of Shatavari (Asparagus racemosus) root extract for perimenopause: randomized, double-blind, placebo-controlled study. Int J Womens Health 2025;17:4057-4073 (PMID 41209045), 2025-11-03. pubmed.ncbi.nlm.nih.gov
  11. Kondamudi S, et al. CL22209, a standardized Asparagus racemosus root extract, demonstrates improved ovarian morphology, menstrual regularity, and metabolic parameters in women with polycystic ovary syndrome in a randomized, controlled trial. Food Nutr Res 2025;69 (PMID 41497317), 2025-12-23. pubmed.ncbi.nlm.nih.gov
  12. Mhatre Y, et al. Efficacy and safety of Shatavari root extract in women with polycystic ovarian syndrome: a randomized, double-blind, placebo-controlled trial. Front Endocrinol (Lausanne) 2026;17:1769773 (PMID 41816216), 2026-02-24. pubmed.ncbi.nlm.nih.gov
  13. Satla M, et al. Safety and efficacy of Shatavari in women with low libido: a randomized, double-blind, placebo-controlled trial. J Med Life 2026;19(7):548-563 (PMID 42751626), 2026-07. pubmed.ncbi.nlm.nih.gov
  14. Chattopadhyay R, et al. SheVari4, a proprietary root extract from Asparagus racemosus, ameliorates menopausal health: insights from a randomized, double-blind, placebo controlled clinical trial. Food Nutr Res 2026;70 (PMID 42571384), 2026-07-21. pubmed.ncbi.nlm.nih.gov
  15. Mishra KG, et al. Evaluation of the effects of Asparagus racemosus extract (ARova5X) supplementation on postmenopausal discomfort. Avicenna J Phytomed 2026;16(5):860-872 (PMID 42769795), 2026. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.